Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Infections Post Transplant

CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR

Bone Marrow Transplantation volume 28, pages 765–768 (2001)Cite this article

Abstract

We prospectively monitored 74 consecutive allogeneic and 50 autologous patients after bone marrow/stem cell transplantation from May 1999 to October 2000 at our institution with quantitative CMV PCR and pp65 antigen assay once weekly from conditioning therapy to days 120 and 80 after transplantation, respectively. Written informed consent was obtained from every patient. CMV prophylaxis consisted of acyclovir during transplant. Additionally all patients received only platelet products from CMV-negative donors. In the case of CMV infection preemptive therapy with gancyclovir was applied. In the case of CMV disease high-dose immunoglobulin was given as well. In the allogeneic setting 16 out of 74 (22%) patients developed a positive PCR. Seven episodes of a positive pp65 antigen assay occurred in six allograft recipients. In the autologous setting no positive assay was found during the whole observation period. Additionally, in 6/16 patients a lymphoproliferative assay was performed during CMV infection. Two patients showed a positive (15 and 5.4) and four a negative (2,1.6,1,1.8) stimulation index. Bone Marrow Transplantation (2001) 28, 765–768.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Zaia J . Viral infections associated with bone marrow transplantation Hematol Oncol Clin North Am 1990 4: 603–623

    Article  CAS  Google Scholar 

  2. Meyers JD, Flournoy N, McCullough J et al. Risk factors for cytomegalovirus infection after human bone marrow transplantation J Infect Dis 1986 153: 478–488

    Article  CAS  Google Scholar 

  3. Wingard JR, Chen DYH, Burns WH et al. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation Blood 1998 71: 1432–1437

    Google Scholar 

  4. Boeckh M, Gooley TA, Myerson D et al. Cytomegalovirus pp65 antigenemia–guided early treatment with gancyclovir versus gancyclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study Blood 1996 88: 4063–4071

    CAS  PubMed  Google Scholar 

  5. Einsele H, Ehninger G, Hebart H et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation Blood 1995 86: 2815–2820

    CAS  PubMed  Google Scholar 

  6. Gerna G, Furione M, Baldanti F et al. Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients Br J Haematol 1995 91: 674–683

    Article  CAS  Google Scholar 

  7. van der Bij W, Torensma R, van Son WJ et al. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes J Med Virol 1988 25: 179–188

    Article  CAS  Google Scholar 

  8. Krause H, Hebart H, Jahn G et al. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease Bone Marrow Transplant 1997 19: 1111–1116

    Article  CAS  Google Scholar 

  9. Storb R, Deeg HJ, Whitehead J et al. Methothrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation New Engl J Med 1986 314: 729–735

    Article  CAS  Google Scholar 

  10. Boivin G, Belanger R, Delage R et al. Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the Cobas Amplicor CMV Monitor PCR test after blood and marrow allogeneic transplantation J Clin Microbiol 2000 38: 4356–4360

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Einsele H, Hebart H, Kauffmann-Schneider C et al. Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection Bone Marrow Transplant 2000 25: 757–763

    Article  CAS  Google Scholar 

  12. Quamruddin AO, Oppenheim BA, Guiver M et al. Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection Bone Marrow Transplant 2001 27: 301–306

    Article  Google Scholar 

  13. Holmberg LA, Boeckh M, Hooper H et al. Increased incidence of cytomegalovirus disease after autologous CD34-select peripheral blood stem cell transplantation Blood 1999 94: 4029–4035

    CAS  PubMed  Google Scholar 

  14. Einsele H, Ehninger G, Steidle M et al. Lymphocytopenia as an unfavourable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation Blood 1993 82: 1672–1678

    CAS  PubMed  Google Scholar 

  15. Quinnan GV, Burns WH, Kirmani N et al. HLA-restricted cyotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infection Rev Infect Dis 1984 6: 156–163

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine I, Bone Marrow Transplantation, University of Vienna, Vienna, Austria

    A Schulenburg, HT Greinix, W Rabitsch, H Loidolt, F Keil, M Mitterbauer & P Kalhs

  2. Department of Virology University of Vienna, Vienna, Austria

    T Watkins-Riedel

Authors
  1. A Schulenburg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T Watkins-Riedel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. HT Greinix
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W Rabitsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H Loidolt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F Keil
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Mitterbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P Kalhs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schulenburg, A., Watkins-Riedel, T., Greinix, H. et al. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR. Bone Marrow Transplant 28, 765–768 (2001). https://doi.org/10.1038/sj.bmt.1703227

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703227

Keywords

This article is cited by

Search

Advanced search

Quick links